"La Clinique de l'Europe est un établissement de santé pluridisciplinaire situé à Amiens, dans les Hauts-de-France. Elle fait partie du Groupe Vivalto Santé, troisième acteur national de l'hospitalisation privée."

During the past decade, Clinique De L Europe; Radiotherapie Chimiotherapie conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 5 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Clinique De L Europe; Radiotherapie Chimiotherapie" are "Breast Cancer" (3 trials), "Colorectal Cancer" (2 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Clinique De L Europe; Radiotherapie Chimiotherapie" in a lesser frequency.

Most popular intervention types in "Clinique De L Europe; Radiotherapie Chimiotherapie" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Trastuzumab" (3 trials), "Bevacizumab" (1 trials), "Docetaxel" (1 trials), "Nab-paclitaxel" (1 trials) and "Paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique De L Europe; Radiotherapie Chimiotherapie" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Clinique De L Europe; Radiotherapie Chimiotherapie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Clinique De L Europe; Radiotherapie Chimiotherapie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinique De L Europe; Radiotherapie Chimiotherapie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".